Here's Why You Should Hold on to PerkinElmer (PKI) Stock Now

Published on December 20, 2021

PerkinElmer (PKI) continues to gain momentum from a solid product portfolio and healthy margins. However, forex woes linger.

Continue reading on website
Other news

Vir (VIR), Glaxo's Xevudy Wins EC Approval for COVID-19

December 20, 2021
Vir Biotechnology, Inc. (VIR) and partner GlaxoSmithKline obtain the European Commission's nod for Xevudy for the early treatment of COVID-19.

Old Wine in New Bottles: Post-Pandemic Lessons for Entrepreneurs from Adam Smith

December 20, 2021
Treating employees well has always been essential to a flourishing capitalist system.